In October 2006, a multidisciplinary approach to treating high risk GU Malignancies was the focus of a symposium in Monte Carlo, Monaco. It brought together an expert faculty panel of Urologists, Medical Oncologists and Radiation Oncologists for an in-depth discussion on the new opportunities and controversies in treatment. The advent of new pharmaceutical treatments, refined surgical procedures and combination therapies potentially redefine the standard of care and increase survival with quality of life.

UroToday.com is pleased to offer the following 11 new state-of-the-art presentations focusing on the latest approaches to high risk and advanced prostate cancer. You can also view the 5 new presentations for high risk and advanced renal cell carcinoma.

Prostate Cancer

Ongoing Trials and the Future In Hormone Refractory Prostate Cancer
(Co-Chair) Cora N. Sternberg, MD, FACP Chairman, Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy
PDF Slide Presentation
On-Demand Multimedia Presentation

The Role Of Bisphosphonates In Metastatic Prostate Cancer
(Co-Chair) Fred Saad MD FRCS Director of Urologic Oncology Professor of Surgery/Urology U of M Chair in Prostate Cancer University of Montreal
PDF Slide Presentation
On-Demand Multimedia Presentation

The Increasing Responsibility Of The Urologist In Maintaining Bone Health In Prostate Cancer Patients
Kurt Miller, MD, Professor and Chairman of Urology at the Benjamin Franklin Medical Center, Charité, Berlin
PDF Slide Presentation
On-Demand Multimedia Presentation

Chemotherapy For High-Risk Disease At RRP
Mario A. Eisenberger M.D. R. Dale Hughes Professor Oncology and Urology The Johns Hopkins University
PDF Slide Presentation
On-Demand Multimedia Presentation

Prevention Of Prostate Cancer:Is This The Way To Go?
Per-Anders Abrahamsson Chairman & Professor Department of Urology Malmö University Hospital, Sweden
PDF Slide Presentation

Identifying The High Risk Patient:What Is Available?
Per-Anders Abrahamsson Chairman & Professor Department of Urology Malmö University Hospital, Sweden
PDF Slide Presentation

The Role Of Surgery In The High Risk Patient
Prof. Dr. Med. Dr. H.C.. Manfred Wirth, Chairman, Department of Urology, Medical School of Carl Gustav Carus, Technical University of Dresden, Germany
PDF Slide Presentation

The Role Of Bisphosphonates In The High Risk Patient
Prof. Dr. Med. Dr. H.C.. Manfred Wirth, Chairman, Department of Urology, Medical School of Carl Gustav Carus, Technical University of Dresden, Germany
PDF Slide Presentation
On-Demand Multimedia Presentation

The Role Of Radiation Therapy In The High Risk Patient
Dr. Heather A. Payne, MD, Consultant in Clinical Oncology University College Hospital London
PDF Slide Presentation
On-Demand Multimedia Presentation

Treating PSA Recurrence
Freddie C. Hamdy, MD Academic Urology Unit University of Sheffield, UK
PDF Slide Presentation

Hormone-Refractory Prostate Cancer
Mario A. Eisenberger, MD, R. Dale Hughes Professor of Oncology and Urology, The Johns Hopkins University
PDF Slide Presentation
On-Demand Multimedia Presentation

Please log-in or register in order to submit comments.

Powered by AkoComment!